Shavit Capital is a private equity general partner firm headquartered in Jerusalem, Israel.
PolyPid, a clinical-stage specialty pharmaceutical company, closed $22m in PE financing co-led by Shavit Capital and Aurum Ventures.
Israeli pharmaceutical company Mapi Pharma has secured a $10m Series A funding round led by Shavit Capital.
Read more news concerning Shavit Capital
A sampling of Shavit Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?